Lauber disease

fundus albipunctatus.

Medical dictionary. 2011.

Look at other dictionaries:

  • Lauber disease — Lau·ber disease (louґbər) [Hans Lauber, Swiss born ophthalmologist in Austria, 1876–1952] fundus albipunctatus; see under fundus …   Medical dictionary

  • fundus albipunctatus — a disorder in which gray or white mottling of the fundus of the eye is associated with night blindness; called also Lauber disease …   Medical dictionary

  • Bat — For other uses, see Bat (disambiguation). Bats Temporal range: 52–0 Ma …   Wikipedia

  • Female infertility — Classification and external resources ICD 10 N97.0 ICD 9 628 …   Wikipedia

  • Palladin — This article is about a protein. For information about the rank, see paladin. Palladin, cytoskeletal associated protein PDB rendering based on 2dm2 …   Wikipedia

  • Dopamine beta hydroxylase — (dopamine beta monooxygenase) Identifiers Symbols DBH; DBM External IDs …   Wikipedia

  • SPINK5 — Serine peptidase inhibitor, Kazal type 5, also known as SPINK5, is a human gene.cite web | title = Entrez Gene: SPINK5 serine peptidase inhibitor, Kazal type 5| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene Cmd=ShowDetailView… …   Wikipedia

  • List of BattleTech characters — The fictional universe of the BattleTech wargaming and science fiction franchise is populated with many significant recurring characters, a number of which appear both in novelizations and in game backstories. Some also factor into the plots of… …   Wikipedia

  • Abolitionism — For other uses, see Abolitionism (disambiguation). Anti slavery redirects here. For the British NGO working for the eradication of slavery, see Anti Slavery International. Am I Not A Man And A Brother? Medallion as part of the anti slavery… …   Wikipedia

  • Programmierter Zelltod — Übergeordnet Zelltod Untergeordnet Apoptose Autophagischer Zelltod Verhornung …   Deutsch Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.